Trial Profile
Phase II trial of concurrent carboplatin, docetaxel and intensity modulated radiation therapy (IMRT) for patients with unresectable stage III non-small cell lung cancer
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2007
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 27 Jul 2007 New trial record.